Antibodies of BCLAF1


1 antibodies are included.     

 Released    NotSatisfied    Submitted    NotReviewed    OnHold    Submitting    Experimented   
RBP Antibody InfoPrimary-HepG2Secondary-HepG2Primary-K562Secondary-K562Primary-UBERONPrimary-Hela
BCLAF1Product_ID: A300-608A
Lot_ID: 1
Source: Bethyl Labs
Target Name: BCLAF1-human		 HepG2_Bethyl_A300-608A_1_BCLAF1.png<br>Caption: IP-Western Blot analysis of HepG2 whole cell lysate using BCLAF1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-BCLAF1 antibody (lanes under 'BCLAF1').
 BCLAF1_Secondary_Western.png<br>Caption: Western blot following shRNA against BCLAF1 in K562 and HepG2 whole cell lysate using BCLAF1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against BCLAF1. Lanes 5-8 follow the same pattern, but in HepG2. BCLAF1 protein appears as the green band, Tubulin serves as a control and appears in red.
 BCLAF1_Secondary_Western.png<br>Caption: Western blot following shRNA against BCLAF1 in K562 and HepG2 whole cell lysate using BCLAF1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against BCLAF1. Lanes 5-8 follow the same pattern, but in HepG2. BCLAF1 protein appears as the green band, Tubulin serves as a control and appears in red.
BCLAF1-K562-CRISPR-A300-608A.png<br>Caption: Western blot following CRISPR against BCLAF1 in K562 whole cell lysate using BCLAF1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against BCLAF1. BCLAF1 protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.